PremiumThe FlyXenetic extends research collaboration with University of Virginia Xenetic enters clinical trial services agreement with PeriNess Xenetic presents preclinical data on DNase I with CAR T cells in murine model PremiumPre-EarningsXenetic Biosciences, Inc. (XBIO) Q3 Earnings Cheat Sheet Xenetic files $50M mixed securities shelf Xenetic enters into material transfer agreement with Tokyo Medical University PremiumThe FlyXenetic reports Q1 EPS (78c) vs. (56c) last year Xenetic Biosciences, Inc. Under Pressure: Shareholder Activism Threatens Stability and Financial Future Xenetic Biosciences Shares Insights on Oncology Platform 
